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Abstract 
Objective: Smoking is one of the modifiable risk factors for multiple diseases, such as cardiovascular diseases 
(CVD), cancer, and diabetes. As smoking aggravates the insulin resistance already presented in T2DM, it 
contributes to increasing glucose in the bloodstream, thus the risk for developing diabetes complications also 
rises. The association between tobacco smoking and glycemic control may explain the role of smoking in 
increasing the risk of diabetes and its complications. The aim of this study is to measure the association between 
cigarette smoking and waterpipe (WP) smoking on Glycemic control. Design and Setting: A descriptive cross-
sectional study was conducted in the NCDEG in Amman, Jordan. Methods: This study recruited 879 male 
participants. The target population consisted of all male patients diagnosed with T2DM, who had two or more 
regular visits to the Diabetes and Endocrinology Clinic. The sample was collected during the period from 15 
November 2015 to 15 March 2016. All patients attending the center during the study period were asked to take 
part in the study. The study subjects were selected using a systematic random sample selection (every two 
patients) from the nursing room. Results: In the study sample, 65.1% of male participants did not achieve the 
target level of HbA1c with a mean 7.6 (SD±1.21); the age of the participants ranged between 30 and 90 years 
with a mean of 58 years (SD±11); the mean duration of diabetes was 9.9 (±7.2) years. In the present study, 
65.1% participants did not achieve the recommended target level for glycemic control (HbA1c <7). About 43% 
of the participants were smokers. An overall 32.3% were cigarette smokers, 69.6% of whom were of poor 
glycemic control; 7.3% were water pipe smokers, 71.4% of whom had poor glycemic control, and the remaining 
3.7% were dual (cigarettes and WP) smokers of whom 75% were of poor glycemic control. This study reported, 
on overall smoking, cigarette smoking and dual smoking were significantly associated with poor glycemic 
control (p-values were 0.017, 0.032) respectively, after adjustment of other confounders including duration of 
diabetes, age of patients 65 years old and above, drug adherence, dietary adherence and waist circumference. On 
the other hand, participants on waterpipe alone were less likely to have good glycemic control compared with 
non-smokers, although it was a positive association but not a significant one. In our study, the number of 
cigarettes smoked was not significant at using binary logistic regression analysis. However, the chi-square test 
indicated that glycemic control differed significantly between participants according to the number of cigarettes 
smoked.  Conclusion: Most of diabetic smokers did not achieve the target level of glycemic control. Smoking 
cigarettes and waterpipe smoking were found to have a significant association with poor glycemic control, after 
adjustment of other confounders such as duration of DM, age, drug adherence, dietary adherence and waist 
circumference. 
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1. Introduction and research problem  
Diabetes mellitus is a chronic metabolic disease with high morbidity and mortality worldwide (1). Globally, the 
International Diabetes Federation (IDF) marked that the prevalence of diabetes was estimated to be about 8.3% 
(387 million people) among adult population worldwide, and the figure will rise up to 10.1% (592 million) in 
2035 with the greatest number between 40 and 59 years of age (2). World Health Organization (WHO) reports 
that Type 2 diabetes (T2DM) comprises 90% of people with diabetes around the world (3). The International 
Diabetes Federation (IDF) reported the prevalence of diabetes in the Arab region to be 16.7% in Saudi Arabia, in 
United Arabic Emirates, 19.5%, in Bahrain, 15.2%, Kuwait, 14.4%, Oman, 13.1% and in Egypt, 10 % (2). In 
Jordan, the study by Ajlouni et al showed that the prevalence of diabetes was estimated to be around 17.1 % (4). 
The main goal of diabetes management is to control blood glucose levels in order to prevent the complications 
associated with diabetes, which are primarily microvascular (such as retinopathy, nephropathy and neuropathy) 
and macrovascular (such as cardiovascular disease) that result from accelerated atherogenesis (5). These 
complications can reduce the quality of life and increase morbidity and mortality rate (6). Glycemic control is a 
key element in diabetes treatment, which is indicated by HbA1c level in the bloodstream attached to hemoglobin 
molecules in the previous two to three months and considered the gold standard for assessing glycemic control. 
Screening and early detection of blood sugar levels prevents and provides better treatment for these patients (6, 7). 
The American Diabetes Association (ADA) guidelines recommended that HbA1c should be below 7% to assess 
the efficacy of therapy and, if not achieved, to recommend adjustments in diet, exercise and medication in order 
to improve patients' glycemic control (8). However, the IDF guidelines have changed the general HbA1c target 
from 6.5% to 7.0% in 2014(9). In addition to controlling blood glucose to prevent diabetic complications, it is 
necessary to control associated modifiable risk factors. The risk factors are classified into two categories: non-
modifiable risk factors, such as age and gender, and modifiable risk factors, which include obesity, dyslipidemia, 
hypertension, physical activity and smoking (10). Smoking is one of the modifiable risk factors for multiple 
diseases, such as cardiovascular disease (CVD), cancer, diabetes, chronic obstructive lung disease and asthma. It 
is associated with insulin resistance, central obesity, dyslipidemia and inflammation (11). Smoking aggravates the 
insulin resistance that is already presented in T2DM, and thus contributes to increasing glucose in the 
bloodstream (12), which in turn, increases the risk for the development of diabetic complications. In addition, 
smoking-related insulin resistance accelerates atherosclerosis and increases cardiovascular diseases risk and 
long-term poor metabolic control (13). The association between tobacco smoking and glycemic control may 
explain the role of smoking in increasing the risk of diabetes and its complications (14). 
 
Tobacco use currently kills approximately 5.2 million people worldwide each year_ a figure expected to upgrade 
to more than 8 million a year by 2030. Half of those deaths occur between the ages of 30 and 69, resulting in a 
loss of 20–25 years of life for smokers versus non-smokers (15). Globally, tobacco-affiliated epidemics are 
expected to take their toll of 10 million deaths annually in the next 20 to 30 years due to global tobacco. More 
than 70 percent of these deaths are in developing countries (16). The statistics show an increasing number of 
people in developing countries smoke tobacco using a waterpipe (WP) (17). Jordanian  Ministry of Health 
reported that the prevalence of smoking increased from 27% to 29% within a period of 2 years after conducting a 
survey in 2005 and 2007 respectively (18). WP smoking rates in the Middle East ranged from11.5% to 40.5% 
compared with cigarette smoking rates of 20.2% to 45.5 % (19). Cigarette smoking is the inhalation of the smoke 
of burning tobacco in cigarettes (20), while water pipe is a way of smoking tobacco in which the vapor passes 
through water before inhalation (21). There are different terms used to describe WP variations, depending on the 
region, and they include WP, Pory or Goza in Egypt, Shisha in Saudi Arabia and Pakistan; in Jordan, Lebanon 
and Syria, it is known as Narghille or Arghila, and Hookah in India. It has variations in size, shape, appearance 
and the type of tobacco used (22, 23). According to health experts, smoking is a psychological addiction (24 ). 
Tobacco smoke contains more than 4,000 chemical substances; more than 200 of these chemicals are toxic and 
cause cancer. Toxic substances enter the circulation in the bloodstream and affect the function of the blood 
vessels and lead to the development of atherosclerotic lesions in the arterial walls. These lesions cause narrowing 
of the arteries, which decreases blood flow. Hardening the arterial walls makes them less elastic and more liable 
to rupture. Additionally, smoking increases platelet adhesions leading to the risk of thrombosis and embolism (24, 
25)
. WP smoking has harmful effects similar to cigarette smoking, and the Nicotine and Tar contents in WP 
smoke are more than in cigarette smoke (23). The World Health Organization estimates that a WP smoker may 
inhale as much smoke as in cigarettes smoking, calculating the risk  during one session of WP to be equivalent to 
smoking 100 cigarettes  (24).  
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1.1. Significance of the Study 
The main goal of diabetes management is to control blood glucose levels in order to prevent complications 
associated with diabetes including microvascular diseases (such as, retinopathy, nephropathy and neuropathy) 
and macrovascular diseases (such as cardiovascular disease). These complications result from accelerated 
atherogenesis, and they reduce the quality of life and increase morbidity and mortality rate (5). The association 
between tobacco smoking and glycemic control may explain the role of smoking in the risk of diabetes and its 
complications (14).The amount of data concerning the effect of tobacco smoking on glycemic control in Jordan 
and in the surrounding Arab countries is limited. Globally, few researches studied the impact of cigarette 
smoking on glycemic control, while there are no available data regarding the effect of waterpipe smoking on 
glycemic control. 
 
2. Aim of the Study 
The aims to determine the association between smoking cigarettes and waterpipe smoking with glycemic control 
and their relationship with other risk factors which include socio-demographic characteristics, anthropometric 
measurements, and clinical data among male patients with T2DM in the NCDEG. 
2.1 Objectives of the Study 
1- To examine the relationship between cigarette smoking and WP smoking on glycemic control in male 
groups with T2DM 
2- To determine the prevalence of cigarette smoking and WP smoking among T2DM patients 
3- To examine the relationship between glycemic control with demographic and clinical characteristics of 
T2DM patients 
 
4- To determine the prevalence of poor glycemic control among male patients with T2DM. 
3. Research Questions  
1- Is there a relationship between cigarette smoking and WP smoking and glycemic control among males with 
T2DM? 
3- Is there a relationship between glycemic control and demographic and clinical characteristics among the 
participants? 
4- What is the prevalence of WP smoking and cigarette smoking among T2DM patients? 
5- What is the prevalence of poor glycemic control among male patients with T2DM? 
 
4. Literature Review 
Source of data used in this study Started with electronic research and focus on full copies of relevant studies 
from CINAHL (cumulative index to nursing and allied health lecture), MEDLINE (medical literature on line) 
and Google search. This chapter presents the literature review regarding glycemic control, diabetes, and 
smoking. A comprehensive literature search was performed to explore the data available on cigarette smoking 
and WP smoking and the increased risk of poor glycemic control complications. This chapter also presents the 
results of the reviewed literature that is related to the study variables. 
 
4.1 Glycemic Control 
The success of diabetes management is calculated by controlling blood glucose levels measured by HbA1c, 
which, according to the American Diabetes Association (ADA) guidelines, should be below 7% (8). A cross-
sectional study in the United Kingdom, conducted from 1998 through 2002, recruited 10,663 participants whose 
age ranged between 17 to 98 years with a mean age of 66 years. This study estimated that about 76% of diabetic 
patients had their HbA1c over 7%. In 1998 and in 2002, 79% and 76% of the participants, respectively, had poor 
glycemic control, defined as HbA1c >7.0%. Participants with poor glycemic control were approximately 2 years 
younger and had been prescribed more oral hypoglycemic agents: 41% received ≥2 oral hypoglycemic agents in 
1998 and 52% in 2002 (27). In a 1999-2000 study of 4874 participants with diabetes by the US National Health 
and Nutrition Examination (NHANES), 37.0% of diabetic patients achieved the target level HbA1c of less than 
7%. Patients who were non-Hispanic, white, with high BMI, and had insulin combination with oral agents were 
found to be significantly associated with poor glycemic control (28). A study, which included 500 patients with 
Journal of Health, Medicine and Nursing                                                                                                                                          www.iiste.org 
ISSN 2422-8419     An International Peer-reviewed Journal 
Vol.32, 2016 
 
58 
T2DM, was conducted in India over one year period from May 2011 to April 2012. This study showed that in 
male participants, hypertriglycermia and gender were significantly associated with poor glycemic control. The 
study illustrated that, though positively correlated but not statistically, elderly age (>50 years), higher BMI, 
longer duration of DM, being only on oral hypoglycemic agents groups, significantly associated with poor 
glycemic control in T2DM patients (29). Another study in San Diego, USA, of patients with T2DM included 573 
individuals with a mean age of 55 years, 69% of whom were females. Participants' ethnic mix was 53% 
Hispanic, 18% Asian, 7% black, 20% white, and 2% other. The study concluded that long duration of diabetes; 
insulin use or different oral agents, young age and high cholesterol were significantly associated with poor 
glycemic control (30).  A study was conducted at the King Khalid University Hospital in Saudi Arabia to evaluate 
glycemic control of diabetic patients. A total of 20,000 participants were involved in the study. Approximately 
90% of the patients were older than 40 years and 90% were obese. In this study, good glycemic control was 
acceptable in approximately 40% of those participants. Cholesterol level was normal in more than 70% of the 
patients, while triglyceride was normal in 56% of them. In about half of the participants, systolic blood pressure 
was not controlled and in about 27%, the diastolic blood pressure was uncontrolled. Good glycemic control was 
significant in males; BMI<30 and Age<50 were significantly associated (31). In a study conducted at Najran 
Armed Forces Hospital in Saudi Arabia, 100 diabetic patients, with a mean age of 58 ± 14.52 years, were 
involved. About 78% of the participants had poor glycemic control regarding their diabetes. Patients younger 
than age 65, female participants, and high levels of triglyceride were significantly associated with poor Glycemic 
control (32). Another study was conducted at Al Faisal University in Saudi Arabia. A total number of 778 T2DM 
patients, with a mean age of 55.03 ± 11.4, participated in the study. Females made up 62.7% of the study sample. 
This study measured the mean HbA1c levels, LDL levels, blood pressure, BMI and the percentage of glycemic 
control. The study also monitored changes during a 4-years span. The mean of the HbA1c was 8.7 in 2006 and 
8.6 within four years. In 2009, 16.6% of diabetic patients had good glycemic control with HbA1c reading of ≤ 
7.0%. While the mean of diabetic patients in the 4 years was 13.55% with good glycemic control (HbA1c goal ≤ 
7%), the systolic blood pressure and BMI increased over 4 years of time. Glycemic control showed a significant 
association with LDL for three years in sequence (33).  
A study conducted in 2010 to determine the factors associated with poor glycemic control among patients with 
T2DM in Jordan included 917 people attending in the NCDEG. The attendants aged between 24 and 84 years, 
with a mean of 57.4 years. Approximately 65.1% of the 917 participants had poor glycemic control (HbA1c ≥ 
7%). This study estimated that with long duration of diabetes, participants who did not adhere to eating plans 
recommended by dietitians, negative attitudes towards diabetes, and increased barriers to adherence were 
significantly associated with poor Glycemic control (34). In another study in Jordan, which included 337 
participants, the mean HbA1c was 7.1%. This study reported that 56.1% participants had poor glycemic control, 
and about 46.6% achieved the target blood pressure of <130/80. Whereas half of the patients achieved the target 
levels of TC, TG and HDL, only 10.4% achieved the target level of LDL. Duration of the disease (>5 years) and 
type of treatment (insulin alone and combination therapy) were significantly associated with poor Glycemic 
control (35). A further study, also conducted in Jordan, included 1000 T2DM patients attending the NCDEG in 
Amman. The participants' mean age was 58.1 (SD 9.3) years. The group of participants with HbA1c ≥ 10% 
decreased from 15.3% to 6.0% after 12 months. Good glycemic control (HbA1c < 7%) increased from 25.4% at 
the first visit to 27.5% in a 12-month follow-up. Low BMI, shorter duration of diabetes and higher baseline 
HbA1c had significant associations with good Glycemic control (36). Another cross-sectional design study was 
conducted between June 2008 and December 2008 at the King Abdullah University Hospital (KAUH) in Jordan. 
The study included 533 T2DM patients, aged 18 years and above. This study reported that poor glycemic control 
was prevalent in about 51.6% of the participants. This study, in addition, showed that long duration of diabetes 
of more than 10 years and decreased family and friend support significantly associated with poor glycemic 
control (37). 
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Table (2-1): Summary of Studies Reporting on Glycemic Control 
 Study 
Location/  
Author(s) 
Year(s) Subjec
ts 
(No.) 
HbA1c 
Cutoff 
Point 
Prevalence 
and Level of 
Glycemic 
Control 
Significant Associated 
Factor(s) 
Age 
UK 
Kathleen et al. 
(27)
 
1998 10,663 >7.0% 76% poor OHA, younger age mean 
66 
USA  
NHANES 
Sharon et al. (28) 
1999, 2000 4,874 >7.0% 37% good  age at diagnosis, insulin in 
combination with oral, high 
BMI, non-Hispanic, white 
ethnicity 
20 and 
older 
USA 
San Diego 
Benoit et al. (30) 
2004 573 >7.0% -poor insulin use, different oral 
agents, younger age, high 
cholesterol, duration of 
DM, BMI 
mean 
55 
India 
Gopinath et al. 
(29)
 
2011-2012 500 >7.0% 78.6% poor male gender, 
hypertriglycermia  
<50  
51-59  
>60 
Saudi Arabia 
 by Al-Rowais 
(31)
 
2009 20,000 >7.0% 40% good male gender, BMI <30, 
Age <50 
older 
than 
40 
years  
Saudi Arabia 
NAFH clinics 
Harrabi et al. (32) 
2014 100 >7.0% 22% good age less than 65 years, high 
levels of total cholesterol 
mean 
58 
Saudi Arabia 
 by Ferwana et 
al. (33) 
2006 and 
2009 
778 >7.0% 16.6% good education level, LDL, age, 
BMI, systolic blood 
pressure 
mean 
55 
Jordan  
at NCDEG  
by Khattab et 
al. (34) 
2010 917 >7.0% 65.1% poor long duration of diabetes, 
not adhering to eating 
plans, negative attitudes 
towards diabetes, increased 
barriers to adherence  
mean 
57.4 
 Jordan  
at JUST  
A Omari et al. 
(35)
 
2009 337 >7.0% 65.1% poor duration of disease >5 
years, type of treatment 
(insulin alone and 
combination therapy) 
- 
Jordan  
at KAUH 
Al-Akour (37) 
2008 533 >7.0% 51.6% poor long duration of diabetes of 
more than 10 years, 
decreased family and friend 
support 
mean 
50.1 
Jordan 
at NCDEG  
by Adham et al. 
(36)
 
2006 1,000 >7.0% from 25% to 
27%  at 12 
month 
follow- up 
low BMI, shorter duration 
of diabetes, higher baseline 
HbA1c 
mean 
58.1 
 
4.2. Smoking  
 Smoking is a risk factor for several diseases such as cardiovascular diseases. Several studies agreed that WP is 
as harmful to the body as cigarette smoking, if not more damaging. A laboratory-based study compared exposure 
to WP toxicants with cigarette smoking among 54 participants. Each participant completed two 45-minute 
sessions, one in which they smoked tobacco using a single cigarette and a WP. Carbon Oxide (CO) increased by 
23.9 ppm for WP and 2.7 ppm for cigarette smoking. Peak WP Carboxyhemoglobin (COHB) levels were three 
times more than those observed in cigarette smoking. Peak nicotine levels did not differ, however. Significant 
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heart-rate increases relative to pre-smoking were observed at 5, 10, 15, 20, 25, and 35 minutes during the 
cigarette session and in 5-minute intervals during the WP session. The single cigarette and the WP used were 
associated with similar peak plasma nicotine concentrations. The study findings support that WP smoking 
presents a risk to non-smokers via secondhand smoke exposure (38). The prevalence of cigarette smoking and WP 
smoking in several countries is increasing. A cross-sectional study conducted in the UK, which included 12,436 
participants in 2012 and another 12,171 participants in 2013, reported that the prevalence of WP use among 
adults was about 12%. Frequent WP use was found to be statistically significant as water pipe was more 
common among adult males than among females, in higher social grades, in younger people and in white 
ethnicity (39). A study conducted in Nablus, Palestine, in 2015, which included 336 individuals estimated that 
22.8% of the participants were WP smokers, and that this rate was higher among males (35.5%) than among 
females (11.5%). In logistic regression analysis, male gender, type of college, older age, negative social norms 
and negative beliefs towards WP smoking contributed to this habit (40). As many as 38 cohort and cross sectional 
studies were conducted to establish an assessment of the prevalence of the use of WP. Those studies reported 
that the prevalence of WP smoking among adults was as follows: Pakistan, 6%, Arab Gulf region, 4% - 12%, 
Australia, 11%, Syria, 9% - 12%, and Lebanon, 15%. Group WP smoking was high in Lebanon (5%), and in 
Egypt (11% - 15) (41). A Cohort study, which included 287 individuals, divided the participants into four groups, 
according to the smoking pattern. The groups were WP smokers, cigarette smokers, dual (cigarettes and WP) 
smokers, and non-smokers. The study established that coronary artery disease (CAD) risk was worse among WP 
smokers than among cigarette smokers, and this may be due to increased tobacco nicotine content. The study 
also found that there was a positive significant association between the severity of CAD and the duration of 
smoking per year amongst both WP and cigarette smokers and between the number of cigarette and WP sessions 
per day (42). 
 
4.3. Smoking and Diabetes 
A relationship does exist between smoking and diabetes. In Italy, a study performed to evaluate the effects of 
cigarette smoking on insulin sensitivity enrolled participants with T2DM and included 28 smokers and 12 non-
smokers. The study found a statistically significant association between cigarette smoking and insulin sensitivity 
after adjustment of potential confounders such as BMI, systolic blood pressure, triglyceride, and HbA1c. The 
number of cigarettes smoked per day had a significant relationship with the insulin-mediated rate of total glucose 
disposal (12). A cross-sectional study in UK, done by European Prospective Investigation into Cancer (EPIC-
Norfolk), examined the association between cigarette smoking and HbA1C. Included in the study were 2,704 
men and 3,385 women. The participants' age ranged between 45 to 74 years. This study concluded that the mean 
HbA1c among smokers was greater than that of non-smokers after adjustment of dietary intake. There was also a 
relationship between HbA1c levels and the number of cigarettes smoked per day. The prevalence of current 
smoking among men was 14.8% in the age group (45 - 54), 11.0% and 9.8% in the age groups (55 – 64) and (65 
– 74) respectively; 12% of men reported being current smokers (14).  A prospective cohort study conducted in 
Australia included 34 diabetic patients whose smoking average number was 24 cigarettes/ day. The participants 
were followed for one year of quitting smoking. The mean age of the group who stopped smoking was 60 years. 
Seven subjects had T1DM and 27 had T2DM. Their mean of HbA1c was 7.7%, which decreased to 7.0 % after 
smoking cessation. This study reported improvement in HbA1c with smoking cessation (43). A cross-sectional 
study, conducted in Pakistan, enrolled 2,032 participants to determine the association between WP smoking and 
metabolic syndrome (MS) which involves central obesity plus any two of the three factors: dyslipidemia, 
hypertension, and diabetes. Among the study sample, 16.0% were current WP smokers. Prevalence of MS was 
significantly higher among current WP smokers (33.1%) as compared to non-smokers (14.8%). WP smokers 
were three times more likely to have MS compared to non-smokers after adjustment of age, sex and social class. 
In addition, WP smokers were significantly more likely to have hypertriglyceridemia, hyperglycemia, 
hypertension and abdominal obesity (44). The National Diabetes Register in Sweden conducted two smoking-
related studies in 1996 and in 2001. Participants with diabetes were 392 in 1996 and 579 in 2001. The studies 
concluded that the rates of smokers with T1DM were 12% in 1996 and 15% in 2001. The rates were great in 
females less than 30 years (12% in 1996 and 16% in 2001) and yet greater in the age group 30 – 59 years (13% 
in 1996 and 17% in 2001) than in older age groups (6% in 1996 and 9% in 2001). The rates of smoking in 
T2DM patients were 10% in 1996 and 12% in 2001. The rates were greater in patients <60 years of age (17% in 
1996 and 22% in 2001) than in older age groups (7% in 1996 and 9% in 2001). Smoker participants with T1DM 
and T2DM had a greater mean of HbA1c but a lower mean of BMI than non-smokers. This study determined 
that smoking significantly associated with increased HbA1c levels but the association decreased with BMI, in 
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both T1DM and T2DM patients (45). Another study of 204 patients with T2DM was conducted in Turkey. The 
mean age of the participants was 34.84 years. The mean age for ex-smokers was 35.83 years and for non-
smokers 41.75 years. This study showed that HbA1c levels were higher in males, but the levels increased further 
with age in smokers compared with non-smokers (46). A study conducted in Nigeria recruited 97 diabetic patients 
visiting Federal Medical Centre. This study reported that 80.4% participants were non-smokers, 8.2% individuals 
were current smokers, and 11.3% were past smokers. The study stated that smokers with T2DM were more 
likely to an increased risk of ischemic heart disease, peripheral vascular disease and stroke (20).  A cross-sectional 
study in Libya enrolled 242 participants who were WP smokers. This study reported that health problems, such 
as chronic cough, hypertension, diabetes, breathlessness, acid peptic disorders, recurrent respiratory infections, 
and ischemic heart disease, were significantly higher among those who had been smoking for the duration of 20 
years or above, and those who smoked more than 3 times per week and aged above 35 years (47). 
 
Table (2-2): Summary of Studies Reporting on Smoking and Diabetes 
Study Location/  
Author(s)/ Year(s) 
Sample Size Result(s)  
Italy  
Benoit et al., 2005 (12) 
 28 smokers and 12 
non-smokers 
Diabetic smokers had higher HbA1c concentrations 
compared to non-smokers. 
Australia  
Gunton et al., 2002  (43) 
34 diabetic smokers There was a significant improvement in HbA1c with 
smoking cessation. 
Turkey  
Fidancı et al., 2015 (46) 
204  HbA1c levels were higher in males and in smokers 
compared to females and to non-smokers. 
UK 
Sargeant et al., 2001  
European Prospective 
Investigation into Cancer (the 
EPIC-Norfolk Study) (14) 
2,704 men and 3,385 
women 
Mean HbA1c among smokers was greater than that of 
non-smokers and was significant after adjustment of 
dietary intake. 
There was a relationship between HbA1c levels and the 
number of cigarettes smoked per day. 
Sweden  
Nilsson et al., 2004 (45) 
314 and 439 Diabetic smoker patients had a higher HbA1c mean but 
a lower BMI mean compared to non-smokers. 
Smoking was associated with HbA1c elevation, 
independently of other risk factors such as, age, sex, 
diabetes duration, use of antihypertensive and anti-lipid 
drugs. 
 
4.4. Summary 
The review of the literature showed that patients with diabetes have poor glycemic control. Several studies 
showed that smoking cigarettes and WP smoking are risk factors to diseases such as cardiovascular diseases and 
diabetes. Smoking increases insulin resistance. Hence the prevalence of poor glycemic control among patients 
with diabetes, which increases their risk of developing microvascular and macrovascular complications. 
 
5. Methods 
This chapter discusses the research design, setting, sample, ethical considerations, and operational definitions of 
variables and statistical analysis plan. The aim of this study is to determine the effect of cigarette and water pipe 
smoking on glycemic control and the relationship with other risk factors that include socio-demographic 
characteristics, anthropometric measurements, and clinical data among male patients with T2DM in the NCDEG. 
 
5.1. Study Design  
A comparative cross-sectional study was conducted in the National Center for Diabetes, Endocrinology and 
6.2Genetics (NCDEG). 
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5.2. Setting 
The NCDEG was established in Amman, Jordan, in 1996 as one of the centers affiliated with the Higher Council 
for Science and Technology. The main goal of this center is to provide quality health care, education and training 
in the fields of diabetes, endocrinology and genetics. 
 
5.3. Sample and Sampling  
The target population consisted of all male patients diagnosed with T2DM, who had two or more regular visits to 
Diabetes and Endocrinology Clinic. The sample was collected during the period from 15 November 2015 to 15 
March 2016. All patients attending the center during the study period were requested to take part in the study. 
The study subjects were recruited using a systematic random sample selection (every two patients) from the 
nursing room. Patients were excluded if there were no previous HbA1c measurements in their files to compare 
with.   
There is evidence in the literature that poor glycemic control remains high (>60%) in patients with type 2 
diabetes, so the sample size was defined by calculating sample size equation:  
Sample size = (Z   ) 2* P (P-1)/ (d) 2, by calculation (1.96)2 * 0.6(1-0.6)/ (0.04)2 = (577 total sample). For the 
purpose of providing broader, clearer and more liable results, the researcher had to increase the number of the 
sample to 879 participants, thus compensating for the missing data. 
 
5.4. The Inclusion Criteria includes Male patients with T2DM, All patients aged over 18 years and Presence of 
a previous chemical laboratory (HbA1c) study in the patient's medical file record. The Exclusion Criteria 
includes all male and female patients, Patients with T1DM and Ex-smokers. 
 
6. Ethical Considerations 
The following principles of ethics in research were ensured before data collection and during the course of the 
study.  
First, the researcher sought approval of NCDEG to conduct the study at the center. Approval of the development 
of the research instrument to use it as the main data collection tool in the present study was also obtained. 
Second, beneficence was achieved by explaining to the participants the aim of the study and the benefits of 
taking part in the study. The participants were ensured that they would not be exposed to any harm physically, 
socially or mentally.  Third, data were collected from the participants who gave a verbal approval 1- to 
participate in this study after explaining to the participants that their participation involved voluntary acceptance 
of answering the questionnaire without any pressure, and 2- to collect data from their medical files without 
mentioning the national number, name or family name of the participant to keep their anonymity. All 
participants were informed that they had the right to ask any questions and to withdraw from the study at any 
time and this would not affect their treatment or the care they received at the center. The researcher conducted 
the interviews with the participants in a private room to ensure privacy. Fourth, the participants were ensured of 
guaranteed anonymity. The participant could fill the questionnaire without a name, and no name would be used 
to identify the participant and each participant would have a code number. In addition, it was emphasized that 
the information provided by the participants would be used for scientific aims only. 
 
7. Data Collection  
7.1. Socio-demographic and Clinical Characteristics Questionnaire 
 A semi-structured questionnaire consisting of sociodemographic data, anthropometric measurements and a 
clinical data sheet was developed. The questionnaire included the following items: information about age, 
occupation (employed, non-employed, or retired), level of education, and income. The clinical characteristics 
and anthropometric data included type of medication used for diabetes, other investigations, duration of diabetes 
and the last three readings of HBA1c, height, weight, BMI, lipid profile, and blood pressure (Appendix A). 
Information regarding patients' self-monitoring to glucose levels, dietary adherence and compliance to physical 
activity and Morisky Medication Adherence Scale were collected (Appendix B). A package including a 
questionnaire instrument consisting of the smoking status was developed (Appendix C).  
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7.2. Medication Adherence Questionnaire  
This tool was developed by Morisky (48).  Medication Adherence Scale (MMAS-8) is an 8-item questionnaire. 
The first seven questions are Yes/ No questions, while the eighth question is a multiple-choice question with the 
answers being (Rarely, Once in a while, Sometimes, Usually, All the time). Each No answer was scored with 0 
point except for the fifth question where the Yes answer was scored with 1 point.  The eighth question was 
scored 0 for Never, whereas any other answer was scored with 1 point. According to the scores adherence is 
classified into 3 categories scores: >2 = low adherence 1 or 2 = adherence 0 = high adherence. The tool was 
translated into Arabic and tested for validity and reliability by Prof. Waleed Saweileh. Permission was obtained 
from the author of the Arabic version of MMAS-8 to be used in this study by e-mail (Appendix B). 
 
7.3. Smoking Status Questionnaire 
Smoking questionnaire in Arabic language for WP smoking was developed by Prof. Omar F. Khabour (49). WP 
tobacco defined as subjects who were current and regular smokers for more than one year. We also asked the 
participants to estimate the age at which they began using cigarettes and/ or water pipes, with the response 
categories of (1) Less than 11; (2) 11 – 14; (3) 15 – 17; (4) 18 – 21; and (5) More than 21 years (Appendix C). 
 
8. Operational Definitions of Variables 
Diagnosis of Diabetes Mellitus, according to the American Diabetes Association criteria for DM, was adopted 
(ADA, 2014) (8). 
1- Diabetes Mellitus, characterized by insulin resistance in peripheral tissue and defect of the beta cell to 
insulin secretion, is defined as: 
- Level of HbA1c ≥ 6.5 
- Fasting plasma glucose ≥ 126 mg/dl after 8 hours of fasting 
- Glucose level of ≥ 200 mg/ dl in a two-hour oral glucose tolerance test 
- Random plasma glucose ≥ 200 mg/ dl. 
 
2- Participants were eligible for this study if they were diagnosed by a physician as having T2DM. 
Duration of Diabetes in years since diagnosis of diabetes was categorized into less than7 years and more than or 
equal 7 years.  
Blood Pressure: People with systolic / diastolic levels ≥140 / 90 mmHg or people, who were on 
antihypertensive medication, were defined as having hypertension (50). 
BMI was categorized into normal if BMI was below 25 kg/ m2, overweight if BMI was 25 – 29.9 kg/ m2, and 
obese if BMI was ≥30 kg/ m2 (51). 
Waist Circumference was considered normal if the value of male WC was <102cm and the value of female WC 
was <88cm, and if more than or equal to these values, obese (American Diabetes Association, 2014) (51). 
Glycemic Status was considered controlled when HbA1c level ≤7% and poor if HbA1c more than 7% 
(American Diabetes Association, 2014) (6). 
Dyslipidemia: Criteria for abnormal lipid profile levels were based on the ADA criteria (American Diabetes 
Association, 2014) (6). HDL was considered low when the level was below 40 mg/ dl in males and below 50 mg/ 
dl in females. LDL was considered high when the level was ≥100 mg/ dl. Dyslipidemia was defined as the 
presence of one or more of the previous abnormalities in serum lipids or patients receiving medications or any of 
the above conditions were classified achieving the condition (6). 
Type of Treatment was categorized into insulin treatment, oral agent treatment alone and mixed insulin and oral 
agents.  
Diabetes Self-management Behavior  
Self monitoring of Blood Glucose: If patients performed at home frequencies of glucose monitoring for 3 days 
or more in the previous 7 days, patients were classified as highly adherent. 
Eating Adherences Recommended by Dietitians:  if a patient's eating frequencies were 3 days and more in the 
previous 7 days, the patient was considered adherent, and if a patient's eating plan was less than 3 days in the 
previous 7 days, the patient was considered non-adherent.   
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Physical Activity Questionnaire (52): The National Institute of Diabetes, Digestive, and Kidney Diseases (2014) 
recommended that a total amount of 150 minutes a week of moderate-intensity aerobics, such as brisk walking, 
should be spent. Physical activity for 3 days or more each week consistently reduced the risk of many chronic 
diseases and other adverse health outcomes. The patients were asked to provide information as follows. Doing 
Physical Activity: Yes if the patient did a physical activity or No if the patient did not; Type of Physical 
Activity: Light, Moderate, Vigorous; Group of Physical Activity: Aerobic, Strength, Stretching; Duration of 
Physical Activity; and Number of Days for Physical Activity per Week. Additionally, the participants were 
requested to give further elaboration in terms of physical activity. In Light Physical Activity, the patients were 
asked to tell if Light Physical Activity was easy, Patients were breathing normally, Patients were not sweating, 
and Patients could talk normally or even sing. In Moderate Physical Activity, we sought to determine if Patients 
felt the activity to be somewhat hard, Patients were breathing quickly, Patients were lightly sweating after about 
10 minutes of activity, and Patients could talk normally but could not sing. In Vigorous Physical Activity, we 
sought to find out if Patients felt the activity to be hard, Patients were breathing deeply and quickly, Patients 
were sweating after a few minutes of activity, and Patients could not talk normally without stopping for a breath. 
Groups of Physical Activity 
- Aerobic exercise uses large muscles, makes your heart beat faster, and makes you breathe harder. Doing 
moderate to vigorous aerobic exercises 30 to 60 minutes a day most days of the week provides many benefits. 
- Strength training to build muscles is a light to moderate physical activity that builds muscles and keeps your 
bones healthy. When you have more muscle and less fat, you will burn more calories because muscle burns more 
calories than fat, even between exercise sessions. 
- Stretching exercises are a light to moderate physical activity that both men and women can do. For example, 
yoga is a type of stretching that focuses on your breathing and helps you relax. 
Smoking  
In this study, respondents who reported smoking at the time of the survey_ current smokers_ were categorized 
into daily smokers or occasional smokers according to the WHO (1998) guidelines. Daily smokers are defined as 
individuals who smoke any tobacco product at least once a day, including those who smoke every day except 
days of religious fasting. Occasional smokers are individuals who smoke any tobacco product, but not every day 
(46)
. Cigarette-smokers were asked about the duration and frequency of smoking (the average number of 
cigarettes smoked per day or week). Smoking definition was based on its active presence in the last one year (20). 
Current WP Smokers are defined as subjects who were current and regular smokers for more than one year. 
The participants were compared at two different levels: 
1. Smokers vs non-smokers 
2. Patients were first divided, according to their smoking habits, into four groups: Group 1: WP smokers only, 
Group 2: Cigarette smokers only, Group 3: Dual smokers (cigarette and WP smokers), and Group 4: Non-
smokers. 
 
Anthropometric Measurement 
Body Mass Index (51) is weight in kilograms divided by square of the height in meters, measured by electrical 
and non-electrical L-shape digital weight scales to the nearest 0.5 cm. Measures in centimeter and meter units 
should be to the nearest 0.5 kg without shoe use and with minimal clothing. 
Waist Circumference is a measurement in centimeters at midpoint between the lower border of the ribs and the 
upper border of the pelvis. 
Hypertension (Blood Pressure) operational definition: the pressure applied by blood on the blood vessels 
during heart contraction and heart relaxation. Heart contraction is called systolic blood pressure and heart 
relaxation is called diastolic blood pressure. Blood pressure measurement is usually done by nurses, using 
electronic sphygmomanometers. NCDEG uses (RIESTAR sphygmomanometers, model number EN 1060). 
Nurses should focus, before measuring blood pressure, on the size of the cuff and bladder in the 
sphygmomanometers. If the patient's body weight is normal, a nurse should use a normal adult blood pressure 
cuff (sized 24cm x 32cm) with a bladder (sized 12cm wide and 23cm long). If the patient is obese, a larger blood 
pressure cuff (35 - 44 cm circumference) should be used. The patient should be in sitting position and the hand 
on the heart level. The patient should take a rest before the nurse measures BP. 
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Biochemical Data 
We used the BIO RAD Variant II TURBO high-performance liquid chromatography method to measure HBA1c 
percentage. Lipid profiles were assayed by the automated spectrophotometer, which uses the enzymatic 
colorimetric method. Kits from Roche Diagnostics were implemented. 
 
9. Statistical Analysis Plan  
We used the Statistical Package for Social Science (SPSS version 20), Data were examined for data entry errors 
and corrected appropriately.Univariate analysis: Descriptive statistics were obtained for continuous analysis of 
variables as means ± SD, and categorical variables as frequencies and percentages. Bivariate analysis: the chi-
square test was used to assess the significance for the differences of categorical variables and the associations 
between dependent and independent variables. Multivariate analysis: using binary logistic regression analysis 
was conducted to determine the factors associated with Glycemic control. The association of a particular variable 
was expressed as odds ratio (OR) with a 95% confidence level (CL). And Results were considered significant at 
a P-value of <0.05. 
 
Results 
This study aims to determine the association between smoking cigarettes and water pipe smoking with glycemic 
control, and to determine the prevalence of glycemic control and associated risk factors among male patients 
with T2DM in the NCDEG. This chapter describes the results to accomplish the purpose of the study. It includes 
a description of the participants' socio-demographic characteristics and clinical and laboratory data. The 
associations between cigarette-smoking, water pipe smoking, socio-demographic characteristics, clinical and 
laboratory data with glycemic control are presented as well. 
Participants' Characteristics 
The study recruited 879 male participants with T2DM. The socio-demographic and anthropometric 
characteristics of the study participants are shown in Table (4-1). The age of participants ranged from 30 to 90 
years with a mean of 58 years (SD±11.0). Most of the participants (43.2%) were in the age group 51 - 64 years. 
More than half of the participants (53.2%) had diabetes for more than 7 years, while 46.8 % of them had diabetes 
for less or equal to 7 years, with a mean duration of 10 years (SD ±7.2). As for the level of education, 61.1% of 
the participants received a higher level of education, while 38.9% of them received secondary education or less. 
About half of the participants had income equal to 500 JDs or more per month, while 49.7% of them were 
having monthly income less than 500 JDs per month. More than half (56.5%) of participant were of high waist 
circumference and described as obese.  The clinical characteristics of the study participant are presented in table 
(4-2). About 65% participants did not achieve the target level of HbA1C with a mean of 7.6% (SD±1.21). Most 
participants (73.5%) were performing glucose self-monitoring regularly, 77.2% were adherent to treatment of 
diabetes, 65% were non-adherent to regular diet, and the majority of the participants (78.7%) were non-
compliant to physical activity. Regarding medical history, seventy-three percent of our study participants had 
HTN, with a mean systolic blood pressure of 136 (SD±14.3) and a mean diastolic blood pressure of 77 (SD±8.6), 
16.4% participants had IHD, 3.9% had CVA and 80% had dyslipidemia. With concern to the type of treatment 
used for the management of diabetes, patients who were on oral hypoglycemic agents (OHA) made up 54.6 % of 
the sample, while 41.7% were on a combination of OHA and insulin therapy; only 3.8% of the patients were on 
insulin therapy alone. 
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Smoking Status 
As shown in table (4-3), 56.8 % of the study participants were non-smokers, while 43.2% of the participants 
were smokers. Of all participants, 32.2% were cigarette smokers alone, 7.3% were waterpipe smokers alone, and 
the remaining 3.7% were dual (cigarettes and WP) smokers. 
 
Table (4-3): Characteristics of Smoking Habits among the Study Participants (n=879) 
Variable Number (%) 
Smoking    
Yes                                   
No 
 
375 (43.2) 
494 (56.8) 
Type of Smoking    
Cigarettes alone 
Waterpipe  alone 
Cigarettes and water pipe 
Non-smoker 
 
280 (32.3) 
63 (7.3) 
32 (3.7) 
493 (56.8) 
Number of Cigarettes Smoked/ Day 
Less than 10 cig/ day 
10 to 20 cig/ day 
1-2 packs/ day 
More than 2 packs/ day 
 
9 (3.2) 
21 (7.4) 
149 (52.3) 
106 (37.2) 
Frequency of Waterpipe Smoking 
At least once/ day                  
At least once/ week                        
At least once/ month 
 
43 (45.7) 
49 (52.2) 
2 (2.1) 
 
Table (4-2): Clinical Characteristics of the Study Participants (n=879) 
Variable Number (%) 
Glycemic Control      mean=7.6, (SD ±1.21) 
Uncontrolled 
Controlled 
 
566 (65.1) 
303 (34.9) 
Dyslipidemia        
No 
Yes 
 
175 (20) 
699 (80) 
Physical Activity 
Non-compliant 
Compliant 
 
685 (78.7) 
185 (21.3) 
Type of Treatment                               
Insulin  
Oral Hypoglycemic Agents 
Insulin and Oral Hypoglycemic Agents 
 
32 (3.7) 
473 (54.6) 
361 (41.7) 
Ischemic Heart Disease 143 (16.4) 
Hypertension 632 (73) 
CVA                           34 (3.9) 
Drug Adherence           
Non-adherent 
Adherent 
 
199 (22.8) 
675 (77.2) 
Self-monitoring 
Non-adherent 
Adherent 
 
231 (26.5) 
642 (73.5) 
Dietary Adherence            
Non-adherent 
Adherent 
 
562 (64.4) 
310 (35.6) 
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Glycemic Control 
About sixty-five percent of the participants did not achieve the target level of HbA1C with a mean HbA1C 7.6% 
(SD±1.21). Glycemic control, according to participants' characteristics, is shown in tables (4-4, 4-5, and 4-5). 
Glycemic control differed significantly between participants according to duration of diabetes, waist 
circumference, smoking status, type of diabetes treatment, dyslipidemia, dietary adherence, physical activity, 
self-monitoring of diabetes and adherence to medications. As shown in table (4-5) and Figure (4-1), most 
diabetic smokers did not achieve the target level of glycemic control. 
 
Table (4-4): Relationship between Glycemic Control and Sociodemographic and Anthropometric Characteristics 
among the Study Participants (n=879) 
Variable Uncontrolled 
N (%) 
Controlled 
N (%) 
P-value 
Age (years)              
≤50 
51-64 
≥65 
 
165 (68.2%) 
245 (65%) 
155 (62.2%) 
 
77 (31.8%) 
132 (35%) 
37 (37.8%) 
0.386 
Duration of DM                       
≤7 
>7 
 
205 (50.6%) 
358 (77.7%) 
 
200 (49.4%) 
103 (22.3%) 
0.000 
Waist Circumference                  
High 
Normal 
 
215 (57.2%) 
348 (71.5%) 
 
161 (42.8%) 
139 (28.5%) 
0.000 
Education                
Secondary or less 
Higher education 
 
230 (67.6%) 
336 (63.5%) 
 
110 (32.4%) 
193 (36.5%) 
0.216 
Occupation                                 
Employed 
Unemployed or Retired 
 
283 (66.1%) 
279 (64%) 
 
145 (33.9%) 
157 (36%) 
0.521 
Monthly Income (JDs)                              
<500 
≥500 
 
275 (65%) 
279 (64.9%) 
 
148 (35%) 
151 (35.1%) 
1.000 
 
Table (4-5): Relationship between Glycemic Control and Clinical Characteristics among the Study Participants 
(n=879) 
Variable Uncontrolled 
N (%) 
Controlled 
N (%) 
P-value 
Dyslipidemia                                       
No       
Yes 
 
101 (58.4%) 
465 (66.8%) 
 
72 (41.6%) 
231 (33.2%) 
0.041 
Type of  Treatment                       
Insulin 
Oral Hypoglycemic Agents  
Insulin and Oral Hypoglycemic Agents  
 
26 (81.2%) 
221 (46.9%) 
314 (87.7%) 
 
6 (18.8%) 
250 (53.1%) 
44 (12.3%) 
0.000 
Ischemic Heart Disease              
No 
Yes 
 
468 (64.7%) 
96 (67.6%) 
 
255 (35.3%) 
46 (32.4%) 
0.563 
Hypertension 
No 
Yes 
 
140 (60.3%) 
422 (67.1%) 
 
92 (39.7%) 
207 (32.9%) 
0.076 
CVA                                                    
No 
Yes 
 
539 (64.8%) 
24 (70.6%) 
 
293 (35.2%) 
10 (29.4%) 
0.584 
Physical Activity 
Non-compliant 
Compliant 
 
472 (69.4%) 
93 (50.3%) 
 
208 (30.6%) 
92 (49.7% 
0.000 
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Self-mentoring                                 
Adherent 
Non-adherent 
 
181 (79.4%) 
385 (60.2%) 
 
47 (20.6%) 
255 (39.8%) 
0.000 
Dietary Adherence                                               
Adherent 
Non-adherent 
 
433 (77.5%) 
133 (43.2%) 
 
126 (22.5%) 
175 (56.8%) 
0.000 
Drug Adherence                             
Adherent 
Non-adherent 
 
174 (87.9%) 
392 (58.4%) 
 
24 (12.1%) 
279 (41.6%) 
0.000 
Health Team  Support                                   
No 
Yes 
 
9 (69.2%) 
553 (65%) 
 
4 (30.8%) 
298 (35%) 
0.502 
0
10
20
30
40
50
60
70
80
Cigarette WP WP and
cigarette
Non
smoker
Good glycemic control
Poor glycemic control
            Figure (4-1): The Association between Glycemic Control and Smoking Status 
 
Multivariate Analysis of Factors Associated with Glycemic Control 
Multivariable logistic regression analysis was performed to examine the net effect of certain variables on 
glycemic control after adjustment of the effects of other variables in the model. As shown in table (4-7), the only 
factors that associated with glycemic control were duration of DM, age, drug adherence, dietary adherence, type 
of smoking habits, and waist circumference, all of which were significant to the model. Participants with short 
duration of diabetes less than or equal 7 years were 2.9 times more likely to have good glycemic control 
compared to participants with long duration of diabetes (more than 7 years). Participants with age group more 
than 64 years old were 2 times more likely to have good glycemic control compared to participants less than 51 
years old (p-value was 0.008). Participants with positive adherence to treatment were 4 times more likely to have 
Table (4-6): Relationship between Glycemic Control and Smoking Habits among the Study Participants 
(n=879) 
Variable Uncontrolled 
N (%) 
Controlled 
N (%) 
P-value 
Type of Smoking    
Cigarettes alone 
Waterpipe alone 
Cigarettes and Water pipe 
Non-smoker 
 
195 (69.6%) 
45 (71.4%) 
24 (75%) 
302 (61.1) 
 
85 (30.4%) 
18 (28.6%) 
8 (25%) 
192 (38.9) 
0.037 
Number of Cigarettes/ Day 
10 to 20 cig/ day 
1-2 packs/ day 
More than 2 packs/ day 
 
13 (44.8%) 
115 (68%) 
91 (79.8%) 
 
16 (55.2%) 
54 (32%) 
23 (20.2%) 
0.001 
Frequency of Waterpipe Smoking 
At least once/ day                  
At least once/ week                        
At least once/ month 
 
34 (79.1%) 
33 (67.3%) 
1 (50%) 
 
9 (20.9%) 
16 (32.7%) 
1 (50%) 
0.353 
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good glycemic control compared to participants were non-adherent to diabetes treatment (p-value 0.000). 
Participants adherent to diet were 3 times more likely to have good glycemic control compared with participants 
who were non-adherent to their diet as recommended by dietitians (p-value was 0.000). 
In addition, subjects who were cigarette smokers and dual (cigarettes and WP) smokers were (0.62, 0.35) times, 
respectively, less likely to have good glycemic control compared with non-smokers, with p-values being 0.017 
for cigarette smokers and 0.032 for cigarette and WP smokers, respectively. It was noticed that more than half of 
the participants had high waist circumference and were (0.049) times lower likely to have good glycemic control 
compared to patients of normal waist circumference (p-value 0.017). On the other hand, participants who were 
WP alone users were 0.52 time less likely to have good glycemic control compared with non-smokers. WP alone 
smokers had a positive but not significant association (p-value 0.072). As for patients who were on a 
combination of insulin and OHA, they were 0.39 time less likely to have good glycemic control compared to 
participants on insulin alone. Their association was positive but not significant (p-value 0.072).  
 
 
Summary 
 In the present study, it was established that 65.1% of the participants did not achieve the recommended target 
level for glycemic control (HbA1c <7). About 43% of the participants were smokers. An overall 32.3% were 
cigarette smokers of whom 69.6% had poor glycemic control. Another 7.3% were waterpipe smokers of whom 
71.4% were of poor glycemic control. The remaining 3.7% were dual smokers, 75% of them had poor glycemic 
control.  
 
10. DISCUSSION 
 This study aims to determine the association between smoking cigarettes and waterpipe smoking with glycemic 
control, and to determine the prevalence of glycemic control and associated risk factors among male patients 
with T2DM in the NCDEG. The study enrolled 879 male participants with T2DM receiving treatment at the 
NCDEG. Smoking was found to be associated with poor glycemic control among T2DM patients. As for the 
Table (4-7): Logistic Regression Analysis of the Factors Associated with Glycemic Control among 
Participants with Type 2 Diabetes 
Variable  OR (95% CI) P-value 
Duration of Diabetes (years) 
≤7 
>7 
 
2.94 (2.01-4.30) 
1 (reference) 
 
0.000 
Age (years) 
≤50 
51-64 
≥65 
 
1 (reference) 
1.54 (.99-2.38) 
1.98 (1.19-3.28) 
 
 
0.053 
0.008 
Type of  Treatment                       
Insulin 
Oral Hypoglycemic Agents  
Insulin and Oral Hypoglycemic Agents 
 
1 (reference) 
1.80 (.7-4.9) 
0.39 (.14-1.1) 
 
 
0.237 
0.072 
Drug Adherence 
Non-adherent 
Adherent 
 
1 (reference) 
3.84 (2.2-6.6) 
 
 
0.000 
Dietary Adherence 
Non-adherent 
Adherent 
 
1 (reference) 
2.66 (1.9-3.8) 
 
 
0.000 
Type of Smoking    
Cigarettes alone 
Waterpipe alone 
Cigarettes and Water Pipe 
Non-smoker 
 
0.619 (.41-.91) 
0.52 (.26-1.06) 
0.35 (.14-.92) 
1 (reference) 
 
0.017 
0.072 
0.032 
Waist Circumference  
Normal  
High 
 
1 (reference) 
0.65 (.46-.93) 
 
 
0.017 
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prevalence of smoking, this study showed that about 43% of the participants were smokers. Our results are 
consistent with a recent study for the Middle East region, which set the rates of smoking 20.2% to 45.5% (53). In 
our study, we determined that 32.3% of our participants were cigarette smokers, 69.6% of them were of poor 
glycemic control. Our study also pointed out that 7.3% participants were water pipe smokers, 71.4% of them had 
poor glycemic control, and that the remaining 3.7% were dual smokers, 75% of whom with poor glycemic 
control. Moreover, our study confirmed that participants less than 50 years were more likely to smoke than 
participants 65-years old and older. Similar to our finding are the results of the American Lung Association, 
which stated in 2007 that patients of younger ages were more than three time likely to smoke than people 65 
years and older (54).  
Smoking induces the insulin resistance existent in T2DM. This leads to increased glucose in the bloodstream. 
Smoking-related insulin resistance accelerates atherosclerosis and increases cardiovascular risk and long-term 
poor metabolic control (12). This finding supports the association between tobacco smoking and poor glycemic 
control and concludes that smoking increases the risk of diabetes and its complications (14).   Most diabetic 
smokers adhered to eating recommendations of dietitians and most of them had normal waist circumference. The 
explanation for this is that nicotine increases energy expenditure and could also decrease appetite. Smoking 
cessation is frequently followed by weight gain (18). Most diabetic smokers were non-compliant to physical 
activity, which was possibly, because smoke decreased their pulmonary function (55). 
This study reported that smoking cigarettes and dual smoking (cigarettes and WP) were significantly associated 
with poor glycemic control. However, participants who were on waterpipe alone were less likely to have good 
glycemic control compared with non-smoking patients; the association was positive, but not significant. 
Additionally, most diabetic smokers did not achieve the target level of glycemic control. This finding is similar 
to other studies which support that cigarette smoking is significantly associated with elevated HbA1c 
concentrations (12, 43, 14, and 46). Also, our study established (by using binary logistic regression analysis) that the 
number of cigarettes smoked was not significant. The chi-square test, nevertheless, indicated that glycemic 
control differed significantly between participants according to the number of cigarettes smoked. This finding is 
contrary to another study that reported the number of cigarettes smoked to be statistically significant with the 
level of HbA1c (14). In addition Our study found significant association between smoking and target level of 
HbA1c after adjusting age, duration of diabetes, waist circumference and diet adherence variables. This finding 
is similar to studies which concluded that the association between smoking and the level of HbA1c was 
independent of BMI, age, duration of diabetes (45) and diet (14).but, not similar to a study with blood pressure and 
patients who used lipid lowering medication (45). 
In this study, 65.1% participants did not achieve the recommended target level for glycemic control (HbA1c <7). 
The level of glycemic control found in this study is similar to the findings of other studies that were reported by 
Sharon et al. (28), Khattab et al. (34), Al-Omari et al. (35) and Al-Rowais (31), in which HbA1c ≥7% was achieved in 
68%, 65.1%, 65.1% and 60% respectively. However, the level of poor glycemic control found in this study is 
lower than other studies reported by Kathleen et al. (27), Gopinath et al. (29), Harrabi et al. (32) and Ferwana et al. 
(33)
, in which HbA1c ≥7% was achieved in 76%, 78.6%, 78% and 84.4% respectively. A higher prevalence of 
good glycemic control was not achieved in the NCDEG, possibly because around two thirds of the participants 
were non-adherent to regular diet plans by dietitians, and the majority of the participants (78.5%) were non-
compliant to physical activity. Factors found to be correlated with good glycemic control were duration of DM, 
age older than 65, positive drug adherence, positive dietary adherence and normal waist circumference. 
This study showed that short duration of diabetes was significantly associated with good glycemic control (less 
than or equal 7 years). This finding is consistent with that reported by other studies (37), (34), (30), (35). It is explained 
by the fact that progressive impairment of insulin secretion and decrease in beta-cell function with longer 
duration of diabetes, makes the response to diet alone or oral agent, unattainable. The United Kingdom 
prospective diabetes study showed that beta cell function decreased during five to ten years (56). In this study, 
participants with poor glycemic control prescribed a combination of insulin and oral hypoglycemic agents were 
compared with participants on insulin alone. This finding is explained by health care providers attempting to 
provide better glycemic control by giving additional different types of medication to treat diabetes and the need 
for higher doses of medication that increases over time. This finding is consistent with other studies (33, 28, and 26). 
The results of this study showed a significant relationship between good glycemic control and normal waist 
circumference. Obesity is progressively worsening among participants with T2DM which may be due to insulin 
and other OHA used (36, 30, 28, 31, and 33). Younger age less than 65 years old was associated with poor glycemic 
control. This finding is consistent with studies reporting that old age more than 65 years old was associated with 
good glycemic control (27, 30, 32, and 31). Positive adherence to medication was more common among participants 
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above 50 years with good glycemic control. The possible explanation for this finding is that most participants in 
this age are afraid of aging and death. Only a small percentage of participants was adherent to dietitian-
recommended regular diet and continued education is important to encourage diet-regime adherence. This 
finding is similar to the finding of another study (34). 
 
11. Conclusion 
Most diabetic smokers did not achieve the target level of glycemic control. Smoking cigarettes and waterpipe 
smoking were found to have a significant association with poor glycemic control, after adjustment of other 
confounders, such as duration of DM, age, drug adherence, dietary adherence and waist circumference. 
 
12. Recommendations 
Smoking increases the risk of diabetic complications. Therefore, it is recommended that  
 A comprehensive strategy should be initiated to assist patients to quit smoking.  
 Health promotion activities such as smoking cessation should be implemented at outpatient clinics, 
schools, mosques, universities and different community settings.  
 Further studies with large cohort should be conducted to give better understanding of the relationship 
between tobacco smoking and glycemic control. 
Strengths of the Study  
 This is the first study in Jordan that reports on the effects of cigarette and waterpipe smoking on 
glycemic control. 
 The large sample size. 
Limitations of the Study 
 Glycemic control may be affected by confounders other than smoking  
 Numbers of waterpipe smokers were small in our study 
 The questionnaire which was used to assess the WP smoking was adapted from a study which was 
conducted on a sample population taken from one center, without checking for the validity and 
reliability of this particular questionnaire.  
 Our results cannot be generalized on the whole community (Jordanian), since the sample which we use 
was taken from one health center (NCDEG). 
 
List of Abbreviations 
ADA: American Diabetes Association 
 BP: Blood Pressure 
BMI: Body Mass Index 
CVA: Cardiovascular Disease 
HbA1c: Glycosylated Hemoglobin 
 HTN: Hypertension 
NCDEG: National Center for Diabetes, Endocrinology and Genetics 
OHA: Oral Hypoglycemic Agent(s) 
OR: Odd Ratio 
SD: Standard Deviation 
SPSS: Statistical Package for Social Science 
T2DM: Type 2 Diabetes 
TG: Triglyceride 
WHO: World Health Organization 
WP: Waterpipe (Arghila) 
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